Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 168
Filter
1.
Arch. Soc. Esp. Oftalmol ; 93(4): 160-168, abr. 2018. graf, tab
Article in Spanish | IBECS | ID: ibc-173112

ABSTRACT

PROPÓSITO: Determinación cuantitativa y cualitativa del proteoma en humor acuoso de pacientes con y sin glaucoma. MÉTODO: Estudio observacional, descriptivo y transversal, de 12 pacientes (8 hombres; 4 mujeres) con y sin glaucoma. Se constituyen 3 grupos de proteínas minoritarias con aportación sérica equimolar de cada uno de los pacientes. Las muestras se han obtenido durante la cirugía de cataratas, de pacientes sin glaucoma (realizada con anestesia retrobulbar [cataract retrobulbar patient -CRP-; n = 4] o tópica [cataract topical patient -CTP-; n = 4]), o de pacientes con glaucoma (realizada con anestesia retrobulbar [glaucoma retrobulbar patient -GRP-; n = 4]). Las muestras de humor acuoso se congelaron a -80°C hasta su procesamiento mediante digestión con tripsina para obtener péptidos trípticos y realizar cromatografía líquida acoplada a espectrometría de masas en tándem (LC-MS/MS), para obtener el proteoma y su expresión diferencial entre grupos. El análisis estadístico se realizó mediante el programa SPSS V.17. RESULTADOS: Doce pacientes, con edad (media ± desviación estándar) de 74,50 ± 9,53 años. Concentraciones proteicas obtenidas; 0,48 ± 0,25μg/μl para CRP, 0,28 ± 0,04 μg/μl para CTP y 0,35 ± 0,16μg/μl para GRP. Identificadas 309 proteínas, de estas 205, 210 y 182 se encuentran en CRP, CTP y GRP, respectivamente. Comunes a los tres grupos 114. Exclusivas 50 de CRP, 58 de CTP y 27 de GRP. CONCLUSIONES: En nuestro estudio piloto, encontramos diferencia cuantitativa en la expresión proteica del humor acuoso entre pacientes con y sin glaucoma, existiendo 27 proteínas exclusivas de pacientes con enfermedad glaucomatos


OBJECTIVE: To determine quantitative and qualitative differences of aqueous humor proteome in patients with and without glaucoma. METHOD: Observational, descriptive and cross-sectional study of 12 patients (8 men; 4 women) with and without glaucoma. There are 3 groups of minority proteins with serum equimolar contribution of each of the patients. Specimens were obtained during cataract surgery from patients without glaucoma (performed with retrobulbar anaesthesia [cataract retrobulbar patient -CRP-;n = 4] or topical [cataract topical patient -CTP-; n = 4]), or from patients with glaucoma (performed with retrobulbar anaesthesia [glaucoma retrobulbar patient -GRP-; n = 4]). The humor proteome samples were frozen at -80°C until processing by trypsin digestion to obtain tryptic peptides, and then performing liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) to obtain the proteome and its differential expression between groups. Statistical analysis was performed using the SPSS V.17 program. RESULTS: The study included 12 patients, aged (mean ± standard deviation) 74.50 ± 9.53 years. Concentrations obtained: 0.48 ± 0.25 μg/μl for CRP, 0.28 ± 0.04 μg/μl for CTP, and 0.35 ± 0.16μg/μl for GRP. A total of 309 proteins were identified, of which 205, 210, and 182 were in CRP, CTP, and GRP, respectively. A total of 114 proteins were common to all three groups, 50 were exclusive to CRP, 58 to CTP, and 27 to GRP. CONCLUSIONS: In this pilot study, a quantitative difference was found in the protein expression of humor among patients with glaucoma, there being 27 proteins unique to patients with glaucomatous disease


Subject(s)
Humans , Male , Female , Middle Aged , Aged , Aged, 80 and over , Proteome/analysis , Aqueous Humor/chemistry , Biomarkers , Glaucoma/surgery , Cataract Extraction/methods , Pilot Projects , Proteomics/methods , Eye/physiopathology , Eye Proteins/chemistry , Cross-Sectional Studies , Paracentesis/methods , Confidence Intervals , Glaucoma/diagnosis
2.
Arch Soc Esp Oftalmol (Engl Ed) ; 93(4): 160-168, 2018 Apr.
Article in English, Spanish | MEDLINE | ID: mdl-29439810

ABSTRACT

OBJECTIVE: To determine quantitative and qualitative differences of aqueous humor proteome in patients with and without glaucoma. METHOD: Observational, descriptive and cross-sectional study of 12 patients (8 men; 4 women) with and without glaucoma. There are 3 groups of minority proteins with serum equimolar contribution of each of the patients. Specimens were obtained during cataract surgery from patients without glaucoma (performed with retrobulbar anaesthesia [cataract retrobulbar patient -CRP-;n=4] or topical [cataract topical patient -CTP-; n=4]), or from patients with glaucoma (performed with retrobulbar anaesthesia [glaucoma retrobulbar patient -GRP-; n=4]). The humor proteome samples were frozen at -80°C until processing by trypsin digestion to obtain tryptic peptides, and then performing liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) to obtain the proteome and its differential expression between groups. Statistical analysis was performed using the SPSS v.17 program. RESULTS: The study included 12 patients, aged (mean±standard deviation) 74.50±9.53 years. Concentrations obtained: 0.48±0.25µg/µl for CRP, 0.28±0.04µg/µl for CTP, and 0.35±0.16µg/µl for GRP. A total of 309 proteins were identified, of which 205, 210, and 182 were in CRP, CTP, and GRP, respectively. A total of 114 proteins were common to all three groups, 50 were exclusive to CRP, 58 to CTP, and 27 to GRP. CONCLUSIONS: In this pilot study, a quantitative difference was found in the protein expression of humor among patients with glaucoma, there being 27 proteins unique to patients with glaucomatous disease.


Subject(s)
Aqueous Humor/metabolism , Glaucoma/metabolism , Proteome/biosynthesis , Aged , Aged, 80 and over , Cross-Sectional Studies , Female , Humans , Male , Middle Aged , Pilot Projects
3.
Semin Cancer Biol ; 10(1): 47-53, 2000 Feb.
Article in English | MEDLINE | ID: mdl-10888271

ABSTRACT

We have characterized microsomal and nuclear histamine sites, designated H(IC), through which this amine acts as an intracellular mediator of platelet aggregation and lymphocyte mitogenesis. A major proportion, at least, of the microsomal H(IC) sites are on cytochromes P450, an important family of microsomal enzymes that are present in all cells, but most abundant in the liver. These enzymes are involved in the metabolism of xenobiotics and natural substrates, including lipid hormones that modulate gene function and cell growth. We have shown that polyamines, hormones (including estrogen, testosterone and progesterone), antihormones (including tamoxifen and flutamide) and various antidepressants and antihistamines, all inhibit histamine binding to P450; we have postulated that, through binding to the heme moiety, intracellular histamine regulates cell function by modulating the catalytic activity of P450 enzymes, an action that may be perturbed by endogenous and exogenous substances. We now demonstrate that, in addition to histamine, melatonin and the biogenic amines dopamine, serotonin and noradrenaline bind to P450 isozymes and to cytochrome C. Thus, heme enzymes in general may represent common targets where multiple bioamines, hormones and drugs interact to influence cell function and growth.


Subject(s)
Biogenic Amines/metabolism , Cytochrome P-450 Enzyme System/metabolism , Histamine/metabolism , Animals , Cell Division , Drug Interactions , Drug Synergism , Humans
4.
J Cell Biochem ; 76(4): 686-94, 2000 Jan.
Article in English | MEDLINE | ID: mdl-10653987

ABSTRACT

The virtually universal family of P-450 isozymes contribute to the regulation of cell growth by modulating the levels of steroids and other lipid messengers for cytoplasmic and nuclear processes, including gene expression. In microsomes from rat liver cells, the concentration ( approximately 1 nmole/mg protein) of cytochromes P-450 approximates that of intracellular binding sites (K(d) 1.0-50 microM) for histamine. The potencies of certain therapeutic drugs to inhibit catalytic activity of, and histamine binding to, cytochromes P-450 in vitro were previously shown by us to be predictive of relative propensities to modulate tumor growth in rodents. Also, we demonstrated that growth-regulating polyamines potently interact with histamine at P-450. We now show that several classes of steroid hormones, antiestrogens, and antiandrogens, as well as various arylalkylamine drugs, all potently inhibit (3)H-histamine binding to cytochrome P-450 (K(i) values: testosterone 0.28 microM, progesterone 0.56 microM, flutamide 1.7 microM, tamoxifen 9.0 microM). Furthermore, all the various hormone and drug ligands are mutually inhibitory in their binding to cytochrome P-450; e.g., K(i) values of androstenedione and progesterone, to inhibit imipramine binding to P-450 (determined by spectral analysis), are 11 nM and 26 nM, respectively. The K(i) value of imiprimine to inhibit binding of androstenedione to P-450 is 3.5 microM. We estimate the total P-450 content in microsomes to be greater in male than in female rats and correlated with the number of binding sites for histamine, but not for steroids and drugs that appear to be more selective for P-450 isozymes. Thus, for at least some isozymes, the homeostatic role of the monooxygenases may be governed by histamine, modulated by endogenous ligands, and perturbed by many foreign molecules.


Subject(s)
Cytochrome P-450 Enzyme System/metabolism , Animals , Binding Sites , Biogenic Amines/metabolism , Cell Division/drug effects , Female , Gonadal Steroid Hormones/metabolism , Gonadal Steroid Hormones/pharmacology , Histamine/metabolism , Imipramine/metabolism , Isoenzymes/metabolism , Ligands , Male , Microsomes, Liver/enzymology , Pharmaceutical Preparations/metabolism , Protein Binding , Rats , Rats, Sprague-Dawley , Spectrophotometry , Steroid Hydroxylases/metabolism , Steroids/metabolism
5.
Cancer Chemother Pharmacol ; 45(4): 298-304, 2000.
Article in English | MEDLINE | ID: mdl-10755318

ABSTRACT

PURPOSE: N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine HCl (DPPE), an intracellular histamine (HA) antagonist with chemopotentiating and cytoprotective properties, is currently in phase 2 and 3 clinical trials in breast and prostate cancer. DPPE modulates growth at in vitro concentrations that antagonize HA binding to cytochromes P450 in rat liver microsomes. HA inhibits P450 metabolism of some drugs. Recent in vitro studies in human colon cancer cells have linked DPPE enhancement of paclitaxel, doxorubicin and vinblastine cytotoxicity to inhibition of the P-glycoprotein (P-gp) pump. Many substrates of P-gp are also substrates of CYP3A4, a P450 isozyme that metabolizes a variety of antineoplastic agents and is highly expressed in some malignant tissues. Therefore, we assessed whether (a) DPPE and HA interact at CYP3A4 and other P450 human isozymes, and (b) DPPE inhibits the catalytic activity of CYP3A4. METHODS: Using spectral analysis, we measured DPPE and HA binding to insect microsomes that express human P450 isozymes 1A1, 2B6, 2D6 or 3A4. Employing thin-layer chromatography, we assessed the metabolism of DPPE by each isozyme and DPPE inhibition of testosterone metabolism by CYP3A4 and by rat liver microsomes. RESULTS: (1) DPPE evoked "type I" (substrate site binding) absorbance-difference spectra with CYP2D6 (K(S) = 4.1 +/- 0.4 microM), CYP3A4 (K(S) = 31 +/- 15 microM) and CYP1A1 (K(S) = 40 +/- 9 microM), but not with CYP2B6. (2) In correspondence with the binding studies, DPPE was metabolized by CYP2D6, CYP3A4 and CYP1A1; no metabolism occurred with CYP2B6. (3) HA evoked "type II" (heme iron binding) absorbance-difference spectra with all four isozymes, with K(S) values in the range 80-600 microM. DPPE inhibited HA (600 microM) binding to CYP2D6 (IC50 = 4 microM, 95% CI= 1.8-8.9 microM) and CYP1A1 (IC50 = 135 microM: 95% CI = 100-177 microM), but stimulated HA (500 and 1000 microM) binding to CYP3A4 (EC50 = 155 microM, 95% CI = 104-231 microM). DPPE did not affect HA binding to CYP2B6. (4) DPPE inhibited the metabolism of testosterone by CYP3A4. The concentration/effect curve was biphasic: DPPE inhibited metabolism by 30% at the first site (IC50 = 3 microM, 95% CI = 0.5-25.5 microM), and an additional 70% inhibition occurred at the second site (IC50 = 350 microM, 95% CI = 215-570 microM). A similar result was observed with rat liver microsomes. CONCLUSION: DPPE is a substrate for CYP3A4, CYP2D6 and CYP1A1, but not CYP2B6. DPPE inhibits testosterone metabolism by interacting at two sites on CYP3A4, the first correlating with its K(S) value to bind the substrate site and the second, with its EC50 value to enhance HA binding to the heme iron. We postulate that (1) the inhibitory effect of DPPE on CYP3A4 activity is mediated directly at the substrate site and indirectly by its enhancement of the binding of HA to the heme moiety; (2) in tumor cells that express high constitutive levels of CYP3A4, potentiation of chemotherapy cytotoxicity by DPPE results, in part, from inhibition of CYP3A4-mediated metabolism and P-gp-mediated efflux of antineoplastic drugs; (3) in normal cells that express low constitutive levels of the isozyme, cytoprotection by DPPE results, in part, from induction of CYP3A4 and P-gp, resulting in an increase both in metabolism and efflux of antineoplastic drugs.


Subject(s)
Adjuvants, Pharmaceutic/pharmacology , Antineoplastic Agents/metabolism , Antineoplastic Agents/pharmacology , Cytochrome P-450 Enzyme System/metabolism , Histamine/metabolism , Mixed Function Oxygenases/metabolism , Phenyl Ethers/pharmacology , Adjuvants, Pharmaceutic/metabolism , Animals , Cell Survival/drug effects , Chromatography, Thin Layer , Cytochrome P-450 CYP3A , In Vitro Techniques , Indicators and Reagents , Isoenzymes/metabolism , Male , Microsomes, Liver/metabolism , Phenyl Ethers/metabolism , Rats , Rats, Sprague-Dawley , Spectrophotometry, Ultraviolet , Testosterone/metabolism
6.
Eur J Pharmacol ; 381(1): R1-3, 1999 Sep 17.
Article in English | MEDLINE | ID: mdl-10528138

ABSTRACT

In previous studies, cytochrome P450 monooxygenases were shown to be appropriately sensitive to structurally diverse compounds varying widely in anesthetic potencies and to increasing carbon-number series of straight chain primary and secondary alcohols and rigid cyclic alcohols. We now report that xenon and nitrous oxide, at one atmosphere, occupy the P450 heme cavity and competitively inhibit catalytic activity. The heme enzymes appear to be the most relevant model of the site of general anesthesia, thus far identified.


Subject(s)
Anesthetics, General/metabolism , Cytochrome P-450 Enzyme System/metabolism , Anesthetics, General/pharmacology , Animals , Binding Sites , Binding, Competitive , Hemeproteins/drug effects , Hemeproteins/metabolism , Microsomes, Liver/drug effects , Microsomes, Liver/metabolism , Nitrous Oxide/metabolism , Nitrous Oxide/pharmacology , Protein Binding , Rats , Xenon/metabolism , Xenon/pharmacology
7.
Eur J Pharmacol ; 358(2): 177-85, 1998 Oct 02.
Article in English | MEDLINE | ID: mdl-9808268

ABSTRACT

Each of a diverse array of compounds, at concentrations reported to effect general anesthesia, when added to liver microsomes, forms a complex with cytochromes P450 to generate, with reference to a cuvette containing microsomes only, a characteristic absorbance-difference spectrum. This spectrum results from a change in the electron-spin state of the heme iron atom induced upon entry by the anesthetic molecule into the enzyme catalytic pocket. The difference spectrum, representing the anesthetic-P450 complex, is characteristic of substances that are substrates for the enzyme. For the group of compounds as a whole, the magnitudes of the absorbance-difference spectra vary only about twofold, although the anesthetic potencies vary by several orders of magnitude. The dissociation constants (Ks), calculated from absorbance data and representing affinities of the anesthetics for P450, agree closely with the respective EC50 (concentration that effects anesthesia in 50% of individuals) values, and with the respective Ki (concentration that inhibits P450 catalytic activities half-maximally) values reported by us previously. The absorbance complex resulting from the occupation of the catalytic pocket by endogenous substrates, androstenedione and arachidonic acid, is inhibited, competitively, by anesthetics. Occupation of and perturbation of the heme catalytic pocket by anesthetic, as monitored by the absorbance-difference spectrum, is rapidly reversible. The presumed in vivo consequences of perturbation by general anesthetics of heme proteins is suppression of the generation of chemical signals that determine cell sensitivity and response.


Subject(s)
Anesthetics, General/pharmacology , Cytochrome P-450 Enzyme System/metabolism , Hemeproteins/drug effects , Microsomes, Liver/drug effects , Animals , Male , Microsomes, Liver/metabolism , Rats , Rats, Sprague-Dawley
8.
Clin Exp Hypertens ; 20(5-6): 601-9, 1998.
Article in English | MEDLINE | ID: mdl-9682916

ABSTRACT

Steroid binding domains of Na,K-ATPase and the nuclear hormone receptors share amino acid sequence homologies. In a ouabain radioligand assay, the potencies of series of planar or bent steroid moieties suggest that the domain in Na,K-ATPase can accommodate compounds with a planar configuration. The A/B -cis, C/D-cis steroid configuration in the cardenolides, in conjunction with appropriate substituents at the 3 and 17 positions, may represent a fortuitous "fit" for the exogenous compounds. It remains to be determined if the putative physiological digitalis-like substance is a member of a hormonal steroid family, an endogenous ouabain-like compound or both.


Subject(s)
Pregnanes/metabolism , Sodium-Potassium-Exchanging ATPase/metabolism , Binding Sites , Humans , Ouabain/metabolism , Pregnanes/chemistry , Receptors, Steroid/chemistry , Receptors, Steroid/metabolism , Sodium-Potassium-Exchanging ATPase/chemistry , Structure-Activity Relationship
9.
J Cell Biochem ; 69(3): 233-43, 1998 Jun 01.
Article in English | MEDLINE | ID: mdl-9581862

ABSTRACT

Histamine and polyamines have been implicated in the mediation of cell proliferation. Our previous work linked the growth-modulatory effects of histamine with its binding to intracellular sites in microsomes and nuclei of various tissues. In this study, we identify cytochrome P450 enzymes as a major component of microsomal intracellular sites in hepatocytes and demonstrate that polyamines compete with high affinity for histamine binding to them. Spectral measurement of histamine binding to P450 in liver microsomes resolved high and intermediate affinity binding sites (Ks1 = 2.4 +/- 1.6 microM; Ks2 = 90 +/- 17 microM) that corresponded to microsomal binding sites (Kd1 = 1.0 +/- 0.9 microM; Kd2 = 57 +/- 13 microM) resolved by 3H-histamine binding; additional low affinity (Kd3 approximately 3 mM), and probably physiologically irrelevant, sites were resolved only by 3H-histamine radioligand studies. As determined spectrally, treatment of microsomes with NADPH/carbon monoxide decreased histamine binding to P450 by about 90% and, as determined by 3H-histamine binding, abolished the high affinity sites and reduced by 85% the number of intermediate sites. Spermine competed potently for 3H-histamine binding: in microsomes, Ki = 9.8 +/- 5.8 microM; in nuclei, Ki = 13.7 +/- 3.1 microM; in chromatin, Ki = 46 +/- 33 nM. Polyamines inhibited the P450/histamine absorbance complex with the rank order of potency: spermine > spermidine >> putrescine. In contrast, histamine did not compete for 3H-spermidine binding in nuclei or microsomes, suggesting that polyamines modulate histamine binding allosterically. We propose that certain P450 isozymes that modulate gene function by controlling the level of oxygenated lipids, represent at least one common intracellular target of growth-regulatory endogenous bioamines and, as shown previously, of exogenous growth-modulatory drugs including antiestrogens, antiandrogens, and certain antidepressants and antihistamines.


Subject(s)
Cell Nucleus/drug effects , Chromatin/metabolism , Cytochrome P-450 Enzyme System/metabolism , Histamine/pharmacology , Microsomes, Liver/drug effects , Polyamines/pharmacology , Animals , Binding, Competitive , Carbon Monoxide/pharmacology , Cell Nucleus/metabolism , Microsomes, Liver/enzymology , Microsomes, Liver/metabolism , NADP/pharmacology , Radioligand Assay , Rats , Tritium
10.
J Toxicol Environ Health A ; 54(1): 63-76, 1998 May 08.
Article in English | MEDLINE | ID: mdl-9588349

ABSTRACT

Electromagnetic-related alteration of cellular functions is well documented for extremely low-frequency low-energy pulsing electromagnetic fields (ELF-EMF). In this study we examined the in vitro effects of static magnetic fields (SMF) on the cellular immune parameters of the C57BI/6 murine macrophages, spleen lymphocytes, and thymic cells. The cells were exposed in vitro for 24 h at 37 degrees C, 5% CO2, to 250-1500 G SMF. Exposure to the SMF resulted in the decreased phagocytic uptake of fluorescent latex microspheres, which was accompanied by an increased intracellular Ca2+ level in macrophages. Exposure to SMF decreased mitogenic responses in lymphocytes, as determined by incorporation of [3H]thymidine into the cells. This was associated with the increased Ca2+ influx in concanavalin A-stimulated lymphocytes. Furthermore, exposure to SMF produced markedly increased apoptosis of thymic cells, as determined by flow cytometry. Overall, in vitro exposure of immunocompetent cells to 250-1500 G SMF altered several functional parameters of C57BI/6 murine macrophages, thymocytes, and spleen lymphocytes.


Subject(s)
Apoptosis , Electromagnetic Fields/adverse effects , Lymphocytes/physiology , Macrophages/physiology , Animals , Calcium/metabolism , In Vitro Techniques , Interleukin-2 , Intracellular Fluid , Mice , Phagocytosis/drug effects
11.
Clin Cancer Res ; 3(8): 1357-61, 1997 Aug.
Article in English | MEDLINE | ID: mdl-9815819

ABSTRACT

Salutary clinical responses to withdrawal of flutamide have been widely reported, indicating the potential of this arylalkylamine antiandrogen to stimulate the growth of prostate cancer. Flutamide is known to inhibit cytochrome P450-mediated testosterone synthesis and metabolism. Our laboratory has shown that arylalkylamine potencies in three in vitro assays of P450 binding or function correspond to a propensity of the drugs to enhance tumor growth in vivo. Accordingly, we measured inhibition by flutamide of (a) histamine binding to cytochrome P450 in rat liver microsomes, as determined spectrally, (b) P450-mediated demethylation of aminopyrine, and (c) DNA synthesis in mouse spleen cells stimulated by concanavalin A, and we compared its potencies in these assays with those of other arylalkylamine pharmaceuticals. Flutamide inhibited histamine binding to P450 (Ki = 31 +/- 7 microM), aminopyrine demethylation (Ki = 39 +/- 2 microM), and mitogenesis (IC50 = 12 +/- 1 microM). In overall potency, it ranked with a group of eight drugs, including the antiestrogen tamoxifen, all linked with enhanced tumor growth. In the context of clinical observations that some patients with prostate cancer benefit from flutamide withdrawal, our findings underline concerns that many arylalkylamine drugs have the potential to stimulate the growth or development of malignancies, including prostate cancer. Tumor growth enhancement by flutamide and other arylalkylamines may result from drug perturbation and/or induction of histamine-binding P450 enzymes involved in the synthesis of steroid and eicosanoid mediators that regulate gene function and cell growth.


Subject(s)
Aminopyrine N-Demethylase/metabolism , Androgen Antagonists/pharmacology , Cytochrome P-450 Enzyme System/metabolism , Flutamide/pharmacology , Histamine/metabolism , Lymphocytes/immunology , Microsomes, Liver/enzymology , Prostatic Neoplasms/pathology , Androgen Antagonists/administration & dosage , Androgen Antagonists/therapeutic use , Animals , Cell Division/drug effects , Cells, Cultured , Drug Administration Schedule , Flutamide/administration & dosage , Flutamide/therapeutic use , Humans , Lymphocyte Activation/drug effects , Lymphocytes/drug effects , Male , Mice , Mice, Inbred BALB C , Models, Biological , Prostatic Neoplasms/drug therapy , Rats , Rats, Sprague-Dawley , Spleen/cytology
12.
J Med Chem ; 40(10): 1439-46, 1997 May 09.
Article in English | MEDLINE | ID: mdl-9154966

ABSTRACT

The preparation of 17beta-substituted 14beta-hydroxysteroid C-3 alpha-L-rhamnopyranosides is described. These derivatives have a 14beta,20-ether, 14beta,20-lactone, or 17beta-CH2CH2OH, -CH2CH2NH2, -CH=CHNO2(E), -CH=CHCOOH(E), -CH(OH)CH2NO2(R), -CH(OMe)CH2NO2(R), -CH2-CH2COOH, or -CH(OH)CH2NH2(R) group. Derivatives were assayed in a radioligand binding assay for [3H]ouabain in membranes from canine heart muscle. The digitalis "receptor" comprises isoenzymes of the ion-pumping enzyme, Na+,K+-ATPase. The 17beta-CH=CHNO2(E), 17beta-CH=CHCOOH(E), and 17beta-CH(OMe)CH2NO2(R) derivatives were the most potent and equivalent to ouabain with low-nanomolar IC50 values. The very potent binding affinity of the disubstituted compound 17beta-CH(OMe)CH2NO2(R) further demonstrates that 17beta-unsaturated substitution is not required for potent binding affinity. This observation may be of value in the separation of cardiotonic and cardiotoxic effects. Tosylation of the 17beta-CH2OH, prepared from the 17beta-CHO by lithium aluminum hydride reduction, yielded the 14beta,17beta-ether. Synthesis of the 17beta-CH2COOH gave the epimeric 14alpha,17alpha- and 14beta,17beta-lactones. Structures have been established by NMR analysis.


Subject(s)
Rhamnose/chemical synthesis , Sodium-Potassium-Exchanging ATPase/metabolism , Animals , Dogs , Magnetic Resonance Spectroscopy , Microsomes/metabolism , Myocardium/metabolism , Ouabain/metabolism , Protein Binding , Radioligand Assay , Rhamnose/chemistry , Rhamnose/metabolism , Structure-Activity Relationship
13.
Eur J Pharmacol ; 321(3): 355-60, 1997 Mar 05.
Article in English | MEDLINE | ID: mdl-9085048

ABSTRACT

Nitric oxide appears to mediate some of the central effects of alcohols. However, the direct effects of alcohols on brain nitric oxide synthase have not been determined. In the present study, we tested on purified nitric oxide synthase from rat brain n-alkan-1-ols, n-alkan-2-ol enantiomers, cycloalkanols, and cycloalkanemethanols. In general, the alcohols inhibited nitric oxide synthase activity noncompetitively. Enzyme inhibitory potencies increased with increasing lipophilicity (increasing carbon number) up to the point of 'cutoff', which was C7 for n-alkan-1-ols and C13 for cycloalkanemethanols, indicating that the alcohol binding site on nitric oxide synthase accommodates a maximum chain length of 6-7 carbon atoms. Before the point of 'cutoff', Ki values for the cyclic alcohols and short chain n-alkanols on nitric oxide synthase were less than their respective anesthetic EC50 values. As reported for tadpole anesthesia, there was no stereoselectivity between enantiomeric pairs of secondary alcohols for inhibition of nitric oxide synthase. These results indicate that the nitric oxide synthase inhibitory potency of alcohols of diverse structure is directly related to lipophilicity and length of the alcohols and that direct inhibition of nitric oxide synthase mediates some of the effects of alcohols even at subanesthetic concentrations.


Subject(s)
Alcohols/pharmacology , Nitric Oxide Synthase/antagonists & inhibitors , Alcohols/chemistry , Animals , Cerebellum/drug effects , Cerebellum/enzymology , Male , Olfactory Bulb/drug effects , Olfactory Bulb/enzymology , Rats , Rats, Sprague-Dawley , Stereoisomerism , Structure-Activity Relationship
14.
Br J Pharmacol ; 120(6): 1158-64, 1997 Mar.
Article in English | MEDLINE | ID: mdl-9134230

ABSTRACT

1. General anaesthetics disrupt normal cell receptivity and responsiveness while sparing vital respiratory processes. Ultimate elucidation of the molecular basis of general anaesthesia presumes the identification of one or more subcellular components with appropriate sensitivity to the entire array of anaesthetics. 2. Previously, we showed the universal cellular enzymes, cytochrome P450 mono-oxygenases, to be sensitive at relevant concentrations to all anaesthetics tested. The potential significance of P450 inhibition by anaesthetics resides in the contribution of this enzyme family, in conjunction with that of cyclo-oxygenases and lipoxygenases, to the generation from arachidonic acid of lipid second messengers, the eicosanoids. 3. We have shown that P450 enzymes model the site of general anaesthesia in the tadpole with respect to (a) an absolute sensitivity to increasing chain-length series of flexible, straight chain primary and secondary alcohols and straight chain diols, (b) an absolute sensitivity to increasing molecular weight series of rigid cyclic alkanols and cyclic alkanemethanols, (c) the points of abrupt change and of reversal (cut-off) in the linear relationship between increasing anaesthetic potency with increasing carbon chain length, and (d) non-differentiation between secondary alkanol enantiomers. These findings reveal the P450 enzyme family as the most relevant biomolecular counterpart of the site of general anaesthesia, thus far identified.


Subject(s)
Alcohols/pharmacology , Anesthetics, General/pharmacology , Central Nervous System Depressants/pharmacology , Cytochrome P-450 Enzyme Inhibitors , Glycols/pharmacology , Isoenzymes/antagonists & inhibitors , Microsomes, Liver/drug effects , Aminopyrine/metabolism , Animals , Male , Microsomes, Liver/metabolism , Rats , Rats, Sprague-Dawley , Structure-Activity Relationship
15.
Mol Carcinog ; 16(2): 68-76, 1996 Jun.
Article in English | MEDLINE | ID: mdl-8645428

ABSTRACT

A group of structurally related drugs representing diverse therapeutic classes share, among a number of pharmacological properties, enhancement of tumor growth in several rodent models of malignancy. One common action, the inhibition of histamine binding to and catalytic activity of cytochrome P450 monooxygenases, is highly correlated with potency to enhance tumor growth. Among members of this drug ensemble, the antiestrogen tamoxifen has been shown in controlled clinical studies to increase the incidence of uterine and gastrointestinal cancer and to accelerate the course of gastric cancer, and the tamoxifen analogue clomiphene has been linked to neuroblastoma and the tricyclic group of antidepressants to ovarian cancer. The determination of drug affinities for protein modulators of cell growth, proliferation, and transformation suggests a strategy for identifying at least some classes of chemicals that impart oncologic risks to humans.


Subject(s)
Antidepressive Agents/toxicity , Antipsychotic Agents/toxicity , Carcinogens/toxicity , Histamine H1 Antagonists/toxicity , Neoplasms/chemically induced , Neoplasms/pathology , Tamoxifen/toxicity , Animals , Cell Division/drug effects , Humans , Stimulation, Chemical , Structure-Activity Relationship
16.
Eur J Pharmacol ; 293(3): 231-5, 1995 Oct 06.
Article in English | MEDLINE | ID: mdl-8666040

ABSTRACT

We reported previously that 18 compounds varying in general anesthetic potency by up to 66 000-fold inhibited, at anesthetic concentrations, the metabolism of arachidonic acid and aminopyrine by cytochrome P450 monooxygenases in rat liver microsomes. Now, we report that P450-mediated para-hydroxylation of aniline is more sensitive to the anesthetics. The Ki values for enzyme inhibition for seven compounds were close to and for seven compounds 5-40 times less than their respective anesthetic potencies. Endogenous substrates with an aniline-like binding mode to P450 include histamine and related imidazoles. Acetone and each of the halogenated compounds, halothane, enflurane, and chloroform, stimulated aniline hydroxylase activity at concentrations well below and above their EC50 values. These potent actions on the universal P450 isoenzymes may contribute to pharmacological effects of the anesthetics associated with levels of drug well below concentrations that effect general anesthesia.


Subject(s)
Anesthetics/pharmacology , Aniline Compounds/metabolism , Cytochrome P-450 Enzyme Inhibitors , Microsomes, Liver/metabolism , Aniline Hydroxylase/antagonists & inhibitors , Aniline Hydroxylase/metabolism , Animals , Dose-Response Relationship, Drug , Hydroxylation/drug effects , Male , Microsomes, Liver/drug effects , Rats , Rats, Sprague-Dawley
17.
J Natl Cancer Inst ; 86(10): 770-5, 1994 May 18.
Article in English | MEDLINE | ID: mdl-7909571

ABSTRACT

BACKGROUND: Present studies of drug-induced tumor growth promotion have evolved from earlier investigations into the mechanism of action of N,N-diethyl-2-[4-(phenylmethyl)phenoxy[ethanamine.HCl, a tamoxifen derivative which potently inhibits lymphocyte mitogenesis in vitro and stimulates tumor growth in vivo. It is thought that potency to bind to intracellular histamine receptors (HIC), some of which are on cytochromes P450, may correlate with tumor growth-promoting activity. PURPOSE: We assessed the effectiveness of five in vitro assays in predicting in vivo tumor growth stimulation by the H1-antihistamines loratadine, astemizole, cetirizine, hydroxyzine, and doxylamine. METHODS: Potency of each agent was ranked 1-5 in each of the following in vitro assays: 1) inhibition of [3H]histamine binding to microsomal HIC, 2) inhibition of histamine binding to microsomal P450, 3) inhibition of the P450-catalyzed demethylation of aminopyrine, 4) inhibition of lymphocyte mitogenesis, and 5) stimulation of tumor colony formation. An overall rank score was assigned to each drug and correlated with tumor growth stimulation in vivo. Two laboratories conducted in vivo studies in a blinded fashion. Female C57BL and C3H mice were given a subcutaneous injection on day 1 of syngeneic B16F10 melanoma cells (5 x 10(5)) or C-3 fibrosarcoma cells (1 x 10(5)), respectively. Mice were randomly assigned to treatment groups, then received a single, daily intraperitoneal injection of an estimated human-equivalent dose (or range of doses) of antihistamine or vehicle control for 18-21 days before being killed. Tumors were surgically removed and wet weights compared statistically among groups. RESULTS: The cumulative potency of each drug in affecting tumor growth or growth mechanisms in the five in vitro assays ranked as follows: Loratidine and astemizole ranked highest and were equally potent, followed in decreasing order by hydroxyzine, doxylamine, and cetirizine. A significant correlation (r = .97; P < .02) was observed between the rank order of potency of the antihistamines in all five in vitro assays and the rank order to enhance tumor growth in vivo: Loratidine and astemizole significantly (P < .001) promoted the growth of both melanoma and fibrosarcoma, hydroxyzine significantly (P < .001) promoted the growth of melanoma, while doxylamine and cetirizine did not promote the growth of either tumor. CONCLUSION: Data demonstrate that the in vitro assays predicted the propensity of each H1-antihistamine to stimulate cancer growth in vivo. IMPLICATION: These in vitro tests may prove valuable to screen potential tumor growth promoters.


Subject(s)
Carcinogens/toxicity , Histamine H1 Antagonists/toxicity , Melanoma, Experimental/chemically induced , Animals , Astemizole/toxicity , Cetirizine/toxicity , Doxylamine/toxicity , Female , Histamine H1 Antagonists/adverse effects , Hydroxyzine/toxicity , Loratadine/toxicity , Mice , Mice, Inbred C3H , Mice, Inbred C57BL , Rats , Rats, Sprague-Dawley
18.
J Pharmacol Exp Ther ; 269(2): 709-16, 1994 May.
Article in English | MEDLINE | ID: mdl-7910211

ABSTRACT

3-Chloro-L-tyrosine (3CT) is an inhibitor of tyrosine hydroxylase, the rate-limiting enzyme for catecholamine synthesis. In vivo inhibition of tyrosine hydroxylase results in lower catecholamine levels. 3CT (0.5 mg/kg), administered as a bolus i.v. to anesthetized uninephrectomized rats, elicited increases of 72% and 44% in urinary sodium concentration and volume, respectively, whereas a dose of 1 mg/kg caused increases of 27% and 29%. 3CT, 1 mg/kg, resulted in a 2-fold increase in plasma aldosterone (ALD); 0.5 mg/kg was without significant effect. At a dose of 1 mg/kg 3CT significantly antagonized the renal effects of atrial natriuretic peptide (ANP) (1.5 micrograms kg-1 min-1 by intrarenal infusion), expressed as an enhanced excretion of urine volume (102 +/- 14 vs. 70 +/- 11 microliters/min) and sodium (16.1 +/- 1.8 vs. 11.5 +/- 1.7 microEq/min) and increased osmolar clearance (171 +/- 12 vs. 144 +/- 13 microliters/min). A dose of 0.5 mg/kg of 3CT did not produce these same responses to ANP. The increased urine flow caused by 3CT may reflect reduced norepinephrine synthesis. The inverse dose-effect relationship of 3CT on urine flow rate may result from concomitant depletion of dopamine (DA) and elevated circulating ALD. The antagonism of 3CT on responses to ANP is not at the receptor level, because 3CT did not compete for [125I] ANP binding or inhibit ANP-stimulated guanylate cyclase in kidney cell membranes. It was proposed that the reduced basal sympathetic and renal DA tone, together with the elevated ALD level, account for this antagonism.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Atrial Natriuretic Factor/antagonists & inhibitors , Gastric Mucosa/drug effects , Kidney/drug effects , Tyrosine 3-Monooxygenase/antagonists & inhibitors , Tyrosine/analogs & derivatives , Animals , Atrial Natriuretic Factor/administration & dosage , Cerebral Ventricles , Diuresis/drug effects , Enzyme Activation , Gastric Acid/metabolism , Gastric Mucosa/metabolism , Guanylate Cyclase/metabolism , Kidney/enzymology , Male , Natriuresis/drug effects , Potassium/urine , Rats , Rats, Sprague-Dawley , Tyrosine/pharmacology
19.
Steroids ; 58(11): 518-23, 1993 Nov.
Article in English | MEDLINE | ID: mdl-8273113

ABSTRACT

5 alpha-pregnane-3 beta,14 beta,20 beta-triol 3-alpha-L-rhamnopyranoside (8) and 3 beta-(alpha-L-rhamnopyranosyloxy)-5 alpha-pregn-14-en-20-one (14) were prepared from uzarigenin by ozonolysis followed by zinc and acetic acid reduction and glycosidation. During the glycosidation reaction leading to (8) the corresponding ortho ester (9) was also obtained. Uzarigenin alpha-L-rhamnopyranoside (15) also was prepared. Synthesis of 5 alpha-pregnane-3 beta,14 beta,20 beta-triol (20) is described. Structures were established by analysis of their NMR spectra. The binding affinity of 5 alpha and 5 beta cardenolide and pregnane derivatives as measured in a radioligand binding assay was determined and their structure-activity relationships compared. The receptor binding affinity of the 5 alpha derivatives is less than that of the corresponding 5 beta derivatives.


Subject(s)
Myocardium/metabolism , Pregnanes/chemistry , Sodium-Potassium-Exchanging ATPase/metabolism , Acetates , Acetic Acid , Animals , Cardenolides/chemistry , Cardenolides/metabolism , Dogs , Glycosides/chemistry , Magnetic Resonance Spectroscopy , Microsomes/metabolism , Molecular Structure , Myocardium/ultrastructure , Ouabain/metabolism , Oxidation-Reduction , Ozone , Pregnanes/metabolism , Structure-Activity Relationship , Zinc
20.
Optom Vis Sci ; 70(2): 118-22, 1993 Feb.
Article in English | MEDLINE | ID: mdl-8446374

ABSTRACT

The angiographic characteristics of central serous chorioretinopathy (CSC) were studied by analyzing digitalized angiograms with an IMAGEnet system. We determined the type of leak, its location, and its distance from the fovea and from the center of the detachment. Round leaks were located farther from the detachment center and farther from the fovea than smokestack leaks. Detachments tended to center on the fovea regardless of the leak to fovea distance. These findings suggest that for serous detachment of the sensory retina to develop and be maintained, there must be a diffuse dysfunctional area of retinal pigment epithelium and a focal leak.


Subject(s)
Choroid Diseases/pathology , Image Processing, Computer-Assisted , Retinal Diseases/pathology , Adult , Exudates and Transudates , Female , Fluorescein Angiography , Fundus Oculi , Humans , Male , Middle Aged , Retinal Detachment/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...